Academic Research - Researcher in the Lab

Pushing the Frontiers of Academic Research

Partner with us and leverage our detailed database and versatile portfolio of tests in your translational and clinical research

To discover ways Foundation Medicine supports biopharma partners, please visit the Biopharma Services page.


Are you searching for a cancer genomic database to leverage in your research?

Contact us to gain access to FoundationCore® with over 800k genomic profiling samples or the Clinico-Genomic Database (CGDB) with over 125K genomic results with real-world clinical outcomes in a variety of tumor types. Partner with us to conduct breakthrough analyses and move cancer research forward.

For more information, contact your regional Medical Science Liaison (MSL) or connect with a Foundation Medicine representative at


Are you searching for a trusted partner to support genomic profiling in your clinical research efforts?

Contact us about our portfolio of comprehensive genomic profiling (CGP) tests that can support your investigator sponsored trial or research efforts. Read how Foundation Medicine supports recent research collaborations: ComboMATCH, LEADER, BeatAML, and LungMAP.

For more information, connect with your regional Medical Science Liaison (MSL) or connect with a Foundation Medicine representative at

Choose a profiling assay from our comprehensive product portfolio


Our Comprehensive Product Portfolio

For more information, connect with you regional Medical Science Liaison (MSL) or connect with a Foundation Medicine representative at

Visit our product page for additional details


Foundation Medicine test offerings may be available for Research Use only (RUO), for Investigational Use only (IUO), as Laboratory Developed tests(LDTs) that have not been cleared or approved by the U.S. Food and Drug Administration(FDA), and/or as an FDA-approved companion diagnostic (CDx).

Choose a monitoring assay for treatment response for genomic profiling


Choose Foundation Medicine as your clinical research partner for CGP

  • Characterize the genomics of your banked samples
  • Enable novel correlative analyses of genomics and study outcomes
  • Use our liquid assay to receive a quantitative ctDNA tumor fraction value for banked samples
  • Our portfolio includes RNA for solid tumors and a liquid monitoring assay to assess ctDNA shed across time
  • Sequence banked samples to conduct correlative analyses that push cancer research forward 
  • Sequence banked samples to compare in-house institutional assays with a commercial test FDA-approved for CDx claims
  • Sequence banked samples collected in an active Clinical Trial and receive biomarker data to enhance your analyses

Choose an FDA-approved or laboratory-developed test for genomic profiling research




Broad Gene Panel

  • Sequencing ~40 million read pairs per sample with results reported for >300 genes in our FDA-approved portfolio

Companion Diagnostic Indications

  • Companion diagnostic for fusions and other challenging variants like MET exon 14
  • Multiple companion diagnostic indications across tumor types in liquid and tissue tests

Complex Biomarkers

  • Biomarker definition and pre-defined complex biomarkers (MSI, TMB, bTMB, ctDNA tumor fraction) available for research efforts

Robust Validation

  • Over 42,000 validation samples run across our FDA-approved portfolio

Need More Details?

We are here to help. Visit our Provider Services page for more information.